%0 Journal Article
%T AAV-mediated human PEDF inhibits tumor growth and metastasis in murine colorectal peritoneal carcinomatosis model
%A Qin Jie Wu
%A Chang Yang Gong
%A Shun Tao Luo
%A Dong Mei Zhang
%A Shuang Zhang
%A Hua Shan Shi
%A Lian Lu
%A Heng Xiu Yan
%A Sha Sha He
%A Dan Dan Li
%A Li Yang
%A Xia Zhao
%A Yu Quan Wei
%J BMC Cancer
%D 2012
%I BioMed Central
%R 10.1186/1471-2407-12-129
%X Recombinant AAV2 encoding hPEDF (rAAV2-hPEDF) was constructed and produced, and then was assigned for in vitro and in vivo experiments. Conditioned medium from cells infected with rAAV2-hPEDF was used for cell proliferation and tube formation tests of human umbilical vein endothelial cells (HUVECs). Subsequently, colorectal peritoneal carcinomatosis (CRPC) mouse model was established and treated with rAAV2-hPEDF. Therapeutic efficacy of rAAV2-hPEDF were investigated, including tumor growth and metastasis, survival time, microvessel density (MVD) and apoptosis index of tumor tissues, and hPEDF levels in serum and ascites.rAAV2-hPEDF was successfully constructed, and transmission electron microscope (TEM) showed that rAAV2-hPEDF particles were non-enveloped icosahedral shape with a diameter of approximately 20 nm. rAAV2-hPEDF-infected cells expressed hPEDF protein, and the conditioned medium from infected cells inhibited proliferation and tube-formation of HUVECs in vitro. Furthermore, in CRPC mouse model, rAAV2-hPEDF significantly suppressed tumor growth and metastasis, and prolonged survival time of treated mice. Immunofluorescence studies indicated that rAAV2-hPEDF could inhibit angiogenesis and induce apoptosis in tumor tissues. Besides, hPEDF levels in serum and ascites of rAAV2-hPEDF-treated mice were significant higher than those in rAAV2-null or normal saline (NS) groups.Thus, our results suggest that rAAV2-hPEDF may be a potential candidate as an antiangiogenic therapy agent.Cancer is a major public health problem in the world and causes millions of death each year. More than 1.5 million new cancer cases and 560,000 deaths from cancer are projected to occur in 2010 in the USA [1]. Surgical resection, chemotherapy, and radiotherapy are conventional therapeutic strategies, which were widely used in clinic. Unfortunately, surgical resection is not sufficiently effective for advanced cancer, and chemotherapy and radiotherapy always induce severe side effects [2,3
%K AAV
%K PEDF
%K Tumor
%K Antiangiogesis
%K Gene therapy
%U http://www.biomedcentral.com/1471-2407/12/129